Pepsin is an enzyme produced in the stomach that helps to break down proteins into smaller peptides. Its global overview is that it is an essential enzyme in the digestion of proteins, as it works alongside other digestive enzymes to break down proteins into smaller components that can be absorbed into the blood and used by cells. Other known functions of pepsin include participating in the defense of the gastric mucosa and modulating gut inflammation.
The global Pepsin market was valued at US$ 24 million in 2022 and is anticipated to reach US$ 47 million by 2029, witnessing a CAGR of 9.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Pepsin Market available at: https://www.themarketreports.com/report/global-pepsin-market-research-report
This report aims to provide a comprehensive presentation of the global market for Pepsin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pepsin.
Global Pepsin key players include Feideli Pharmaceutical, A. Constantino & C., Sichuan Deebio Pharmaceutical, Chongqing Qquanxin Xiangsheng, Kin Master, etc. Global top five manufacturers hold a share about 80%. APAC is the largest consumption market, with a share about 55%, followed by Europe, with a share about 30 percent. In terms of product, High Activity is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmaceuticals, followed by Inspection & Quarantine, Health Supplements, etc.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1395995
Release by:
Shirish Gupta
Marketing Manager
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email:sales@themarketreports.com